A small molecule C11, which specifically inhibited the IRES activity of c-MYC by blocking the interaction of hnRNP A1 and IRES, exerted a synergistic anti-glioblastoma effect in combination with mTOR inhibitor rapamycin or PP242. This evidence concerns the gene MYC and glioblastoma.